PDF) Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial | PLOS ONE
Christian Pagnoux, MD MSc MPH 19 November 2015
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
PDF) Update on eosinophilic granulomatosis with polyangiitis
JCM | Free Full-Text | B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis
PDF) Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort - Comarmond - 2013 - Arthritis & Rheumatism - Wiley Online Library
PDF) Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis
Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review
Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Metaâ•'Analysis of Test Accuracy and Benefits and Ha
MAINtenance of remission with RITuximab versus azathioprine for patients with newly-diagnosed or relapsing Eosinophilic Granulom
Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study | Arthritis Research & Therapy | Full Text
ANCA associated vasculitis - ScienceDirect
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials - ScienceDirect
PDF) Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
Five factors score in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss; EGPA): to use or not to use?
Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a n
![PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51ebf4558271a5eedd8568631edf87751abe1e87/8-Table5-1.png "PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar")
PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss; EGPA): to use or not to use? | Annals of the Rheumatic Diseases
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
PDF) Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience
The Korean Journal of Internal Medicine
2 Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndro
